---
title: "Edwards Lifesciences to Host Earnings Conference Call on July 23, 2026 | EW Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292895742.md"
description: "Edwards Lifesciences (NYSE: EW) will announce its operating results for the quarter ended June 30, 2026 after market close on July 23, 2026. The company will host a conference call at 5:00 p.m. ET to discuss these results. Participants can dial (877) 704-2848 or (201) 389-0893, or listen live and archived via the Investor Relations section of edwards.com."
datetime: "2026-07-16T03:05:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292895742.md)
  - [en](https://longbridge.com/en/news/292895742.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292895742.md)
---

# Edwards Lifesciences to Host Earnings Conference Call on July 23, 2026 | EW Stock News

See more from StockTitan in Google Search and AI answers.Adds StockTitan as a preferred source · opens Google

Add on Google

IRVINE, Calif.--(BUSINESS WIRE)--

Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended June 30, 2026 after the market closes on Thursday July 23, and will host a conference call at 5:00 p.m. ET that day to discuss those results.

To participate in the conference call, dial (877) 704-2848 or (201) 389-0893. The call will also be available live and archived on the “Investor Relations” section of the Edwards website at ir.edwards.com.

**About Edwards Lifesciences**

Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. Discover more at www.edwards.com and follow us on LinkedIn, Facebook, Instagram and YouTube.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260716585231/en/

**Media Contact:** Amy Meshulam media@edwards.com  
**Investor Contact:** Gerianne Sarte Investor\_Relations@edwards.com

Source: Edwards Lifesciences Corporation

### Related Stocks

- [EW.US](https://longbridge.com/en/quote/EW.US.md)

## Related News & Research

- [Edwards Lifesciences (NYSE:EW) Issues Earnings Results, Beats Expectations By $0.04 EPS](https://longbridge.com/en/news/293667107.md)
- [Edwards Lifesciences Corporation $EW Shares Acquired by Andra AP fonden](https://longbridge.com/en/news/293434311.md)
- [Edwards Lifesciences Holding lifts Carvolix stake to 11.65% of capital, 9.07% voting rights](https://longbridge.com/en/news/293729797.md)
- [Edwards Earnings Add Fuel To Bullish MedTech Thesis, Analyst Says](https://longbridge.com/en/news/293778081.md)
- [Analyst Maintains Hold on Edwards with Neutral Risk-Reward and Reiterated $85 Price Target Amid Pending TAVR Catalysts](https://longbridge.com/en/news/293780167.md)